OTC agents for GERD - - RNweb
Web Poll
Would remote electronic ICU monitoring improve patient care in your facility?
Yes
No
Yes
91%
No
9%
Thank you for participating in our poll.
Subscribe to our sister nursing publications

Get a FREE subscription to:


Healthcare Traveler

OTC agents for GERD


RN
Volume 1, Issue 71

Non-antacid OTC remedies for gastroesophageal reflux disease (GERD) comprise histamine-2 (H2) blockers and proton pump inhibitors (PPIs). H2 blockers revolutionized GERD therapy. Gastric H2 receptor activation starts acid production and may trigger GERD. OTC H2 blockers include cimetidine (Tagamet HB), ranitidine (Zantac), famotidine (Pepcid), and nizatidine (Axid). Durations, elimination, and side effects vary. Cimetadine is associated with CNS toxicities (including seizures), renal disease complications due to accumulation, and many drug interactions. Refer nonresponders to a doctor.

PPIs supplanted H2 blockers just as H2 blockers replaced antacids. PPIs irreversibly block the proton pump of the gastric parietal cell, reducing acid production more effectively than H2 blockers. The only PPI drug available OTC is omeprazole (Prilosec). PPIs are generally well tolerated. Side effects can include headache, diarrhea, nausea, and abdominal pain. Adult GERD patients should start with 20 mg of omeprazole daily for four to eight weeks. Patients should consult a doctor first, even with OTC drugs.








JAMES M. WOOTEN, PharmD, a member of the RN editorial board, is an associate professor of medicine at the University of Missouri School of Medicine, in Kansas City, MO.

Sources

DeVault, K. R., & Castell, D. O. (2005). Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol, 100(1), 190.

Merck Manual Home Edition. "Antacids: Over-the-counter (OTC) drugs." 2003. (1 Nov. 2007).

National Guideline Clearinghouse. "Gastroesophageal reflux disease (GERD)." 2007. (1 Nov. 2007).

Other Articles from RN
Chocolate lovers rejoice!
More fentanyl patch overdoses spur new warning
Innovations in Practice: Get moving to fight diabetes
Profile of risk factors for Alzheimer's expanded
New drug approved for renal cell carcinoma
Search
Make This Page Your Home Page!
Customized Patient Education Handouts
Clinical Resources
powered by Mediwire
SEARCH:
 
View All Topics
Source: RN,
Click here